Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Cash flows from operating activities:
Net income	$ 109,557	$ 138,665
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Equity in income of unconsolidated joint ventures	(6,742)	(6,610)
Distributions of earnings from unconsolidated joint ventures	13,444	6,500
Amortization of debt issuance costs and premiums	889	860
Depreciation and amortization	8,815	9,335
Deferred income taxes	0	2,300
Stock-based compensation	7,558	7,921
Inventory impairments and land option contract abandonments	1,455	1,298
Changes in assets and liabilities:
Receivables	39,258	10,105
Inventories	(416,363)	(107,536)
Accounts payable, accrued expenses and other liabilities	(99,031)	(38,471)
Other, net	6,839	4,151
Net cash provided by (used in) operating activities	(334,321)	28,518
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	0	(3,138)
Return of investments in unconsolidated joint ventures	556	0
Purchases of property and equipment, net	(11,220)	(9,454)
Net cash used in investing activities	(10,664)	(12,592)
Cash flows from financing activities:
Borrowings under revolving credit facility	180,000	0
Repayments under revolving credit facility	(80,000)	0
Payments on mortgages and land contracts due to land sellers and other loans	0	(917)
Issuance of common stock under employee stock plans	445	8,804
Stock repurchases	(50,000)	(50,000)
Tax payments associated with stock-based compensation awards	(15,884)	(16,505)
Payments of cash dividends	(19,311)	(16,355)
Net cash provided by (used in) financing activities	15,250	(74,973)
Net decrease in cash and cash equivalents	(329,735)	(59,047)
Cash and cash equivalents at beginning of period	599,193	727,342
Cash and cash equivalents at end of period	$ 269,458	$ 668,295